Related Experiment Video
Updated: Sep 16, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Comparison between ondansetron and granisetron in preventing nausea and vomiting after laparoscopic cholecystectomy:
Waleed D Khubzan1, Mohammed H Albagieh1, Ruyuf A Nathif1
1From the Faculty of Medicine (Khubzan); from the Department of Surgery (Mahfouz), Faculty of Medicine, Taif University, Taif, from the Faculty of Medicine (Albagieh, Alsaeed), Imam Mohammed Ibn Saud Islamic University, from the Intensive Care Unit (Nathif), Ministry of National Guard Health Affairs, Riyadh, from the Faculty of Medicine (Alshamrani), University of Jeddah, Jeddah, from the Faculty of Medicine (Alharbi), Unaizah University, Unaizah, and from the Faculty of Medicine (Sharahili), Jazan University, Jazan, Kingdom of Saudi Arabia.
Objectives:
To find the most optimal drug for post-operative nausea and vomiting (PONV) prophylaxis after laparoscopic cholecystectomy (LC) by comparing ondansetron and granisetron.
Methods:
We carried out our study in adherence to the Preferred Reporting Items for Systematic reviews and Meta-Analyses instructions. Google Scholar, PubMed, Web of Science, and Ovid MEDLINE (through November 2024) were searched for studies comparing ondansetron and granisetron after LC. Primary outcomes include the incidence of PONV at 0-12 hour and 0-24 hour time points; secondary outcomes included rescue anti-emetic use and adverse effects. All data analysis and the quality assessment were carried out by utilizing review manager 5.4.
Results:
A total of 21 studies encompassing 1539 patients were included; 17 of them were eligible for meta-analysis. Compared with ondansetron, granisetron was effective in reducing nausea (15.2% vs. 25.4%; risk ratio [RR]=1.67, I2=7%, p=0.0001) and vomiting (10.3% vs. 18%; RR=1.73, I2=49%, p=0.001) within the first 12 hours. At 24-hour time point, granisetron was once again superior in reducing the episodes of nausea (21.8% vs. 38.5%, I2=35%) and vomiting (13.4% vs. 23.3%, I2=52%), with low-to-moderate heterogeneity. Patients on granisetron required less rescue anti-emetics (10.7% vs. 23.1%; RR=2.14, I2=32%, p<0.0001). Adverse effects were also fewer with granisetron (p=0.04).
Conclusion:
According to our findings, granisetron was superior in preventing PONV when compared to ondansetron following LC, with fewer rescue anti-emetics and adverse effects. Further research on cost-effectiveness and optimal dosing is required.PROSPERO No. ID: CRD42024623780.
More Related Videos
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...

